Dr. Adam Wende delivered a seminar on cutting-edge epigenetic research in the setting of heart disease at Washington University in St. Louis (WashU). Dr. Wende’s presentation, titled “Metabolic signaling in transcriptional control of heart failure,” took place on September 05, 2024. Wende had previously received his PhD from WashU.
This seminar highlighted recent breakthroughs in Wende Lab’s research on how poor glycemic control, even when corrected, continues to influence disease progression. His seminar presented compelling evidence for glucose-mediated regulation of transcriptional changes linked to pathological cardiac remodeling.
Congratulations to Dr. Wende for this prestigious opportunity!
